Validation of primed in situ labeling (PRINS) for interphase analysis: Comparative studies with conventional fluorescence in situ hybridization and chromosome analyses

Cancer Genetics and Cytogenetics

Volumn 108, Issue 2, 1999, Pages 100-106

  Velagaleti, GopalRao V N ^a   Tharapel, Sugandhi A ^b   Tharapel, Avirachan T ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ANEUPLOIDY; ARTICLE; CANCER GENETICS; CHROMOSOME 12; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; INTERMETHOD COMPARISON; INTERPHASE; PRIORITY JOURNAL;

ANEUPLOIDY; BASE SEQUENCE; CELLS, CULTURED; DNA PRIMERS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; PRIMED IN SITU LABELING; REPRODUCIBILITY OF RESULTS;

EID: 0033555706     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00124-1     Document Type: Article

References (31)

1. Hopman A.H.N., Ramaekers F.C.S., Raap A.K., Beck J.L.M., Devilee P., Van Der Ploog M., Vooijs G.P. In situ hybridization as a tool to study numeric chromosome aberrations in solid bladder tumors. Histochemistry. 89:1988;307-316.
2. Losada A.P., Wessman M., Tiainen M., Hopman A.H.N., Willard H.F., Sole F., Caballin M.R., Woessner S., Knuutila S. Trisomy 12 in chronic lymphocytic leukemia. an interphase cytogenetic study Blood. 78:1991;775-779.
3. Anastasi J., Le Beau M.M., Vardiman J.W., Fernald A.A., Larson R.A., Rowly J.D. Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells. a simple and sensitive method Blood. 79:1992;1796-1801.
4. Cuneo A., Wlodarska I., Sayed Aly M., Piva N., Carli M.G., Fagioli F., Tarrarico A., Pazzi I., Ferrari L., Cassiman J.J., Van Den Berghe H., Castoldi G.L. Non-radioactive in situ hybridization for the detection and monitoring of trisomy 12 in B-cell chronic lymphocytic leukemia. Br J Haematol. 81:1992;192-196.
5. Brizard F., Brizard A., Guilhot F., Tanzer J., Berger R. Detection of monosomy 7 and trisomies 8 and 11 in myelodysplastic disorders by interphase fluorescent in situ hybridization. comparison with acute nonlymphocytic leukemia Leukemia. 6:1994;1005-1011.
6. Flactif M., Lai J.L., Preudhomme C., Fenaux P. Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndrome. Leukemia. 6:1994;1012-1018.
7. Sandberg A.A., Turec-Carel C., Germill R.M. Chromosomes in solid tumors and beyond. Cancer Res. 48:1988;1049-1059.
8. Teyssler J.R. The chromosomal analysis of human solid tumors. a triple challenge Cancer Genet Cytogenet. 37:1988;103-125.
9. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F Mitelman, ed. S. Karger, Basel.
10. Koch J., Kolvaraa S., Gregersen N., Petersen K.B., Bolund L. Oligonucleotide-priming methods for the chromosome-specific labeling of alpha satellite DNA in situ. Chromosoma. 98:1989;259-265.
11. Velagaleti G.V.N., Tharapel S.A., Martens P., Tharapel A.T. Rapid identification of marker chromosome using primed in situ labeling (PRINS). Am J Med Genet. 71:1997;130-133.
12. Velagaleti G.V.N., Carpenter N.J., Tharapel A.T. Clinical application of primed in situ labeling (PRINS). rapid identification of a marker chromosome in a fetus Ann Genet. 40:1997;154-157.
13. Phillips O.P., Velagaleti G.V.N., Emerson R.L., Tharapel A.T., Shulman L.P. Confirmation of fetal aneuploidy with primed in situ hybridization on amniotic fluid during selective fetal reduction. Prenat Diagn. 17:1997;586-588.
14. Velagaleti GVN, Phillips OP, Tharapel SA, Tharapel AT, Shulman LP (in press): Rapid assessment of aneuploidy in prenatal samples. Am J Obstet Gynecol.
15. Pellestor F., Girardet A., Lefort G., Andreo B., Charlieu J.P. The use of PRINS technique for a rapid in situ detection of chromosomes 13, 16, 18, 21, X and Y. Hum Genet. 95:1995;12-17.
16. Bentz M., Schroeder M., Herz M., Stilgenbauer S., Lichter P., Doehner H. Detection of trisomy 8 on blood smears using fluorescence in situ hybridization. Leukemia. 7:1993;752-757.
17. Fiegl M., Tueni C., Schenk T., Jakesz R., Gnant M., Reiner A., Rudas M., Pirc-Danoewinata H., Marosi C., Huber H., Drach J. Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumor heterogeneity in breast cancer. Br J Cancer. 72:1995;51-55.
18. Gosden J., Hanratty D., Starling J., Fantes J., Mitchell A., Porteous D. Oligonucleotide-primed in situ DNA synthesis (PRINS). a method for chromosome mapping, banding, and investigation of sequence organization Cytogenet Cell Genet. 57:1991;100-104.
19. Gosden J., Hanratty D. PCR in situ. a rapid alternative to in situ hybridization for mapping short, low copy number sequences without isotopes Biotechniques. 15:1993;78-80.
20. Gosden J., Lawson D. Rapid chromosome identification by oligonucleotide-primed in situ DNA synthesis (PRINS). Hum Molec Genet. 3:1994;931-936.
21. Gosden J., Lawson D. A rapid method for chromosome identification by detecting repeated sequences in situ. Cytogenet Cell Genet. 68:1995;57-60.
22. Pellestor F., Girardet A., Lefort G., Andreo B., Charlieu J.P. A polymorphic alpha satellite sequence specific for human chromosome 13 detected by oligonucleotide primed in situ labeling (PRINS). Hum Genet. 94:1994;346-348.
23. Pellestor F., Girardet A., Lefort G., Andreo B., Charlieu J.P. Rapid in situ detection of chromosome 21 by PRINS technique. Am J Med Genet. 56:1995;393-397.
24. Anastasi J., Le Beau M.M., Vardiman J.W., Westbrook C.A. Detection of numerical chromosomal abnormalities in neoplastic hematopoietic cells by in situ hybridization with a chromosome-specific probe. Am J Pathol. 136:1990;131-139.
25. Eastmond D.A., Pinkel D. Detection of aneuploidy and aneuploidy-inducing agents in human lymphocytes using fluorescence in situ hybridization with chromosome-specific DNA probes. Mutat Res. 234:1990;303-318.
26. Kibbelaar R.E., Kok F., Dreef E.J., Kleiverda J.K., Cornelisse C.J., Raap A.K., Kluin P.M. Statistical methods in interphase cytogenetics. an experimental approach Cytometry. 14:1993;716-724.
27. Eastmond D.A., Schler M., Rupa D.S. Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells. Mutat Res. 348:1995;153-162.
28. Escudier S.M., Pereira-Leahy J.M., Drach J.W., Weier H.U., Goodacre A., Cork M.A., Trujillo J.M., Keating M.J., Andreeff M. Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia. Blood. 81:1993;2702-2707.
29. Kwong Y.L., Fang J., Ching L.M., Liu H.W., Liang R.H.S., Chan L.C. Trisomy 12 in chronic lymphocytic leukemia. an interphase cytogenetic study by fluorescence in-situ hybridization Cancer Genet Cytogenet. 72:1994;83-85.
30. Qumsiyeh M.B., Tharapel S.A. Interphase detection of trisomy 12 in B-cell chronic lymphocytic leukemia by fluorescence hybridization in situ. Leukemia. 6:1992;602-605.
31. Wilkens L., Komminoth P., Nasarek A., Wasielewski R.V., Werner M. Rapid detection of karyotype changes in interphase bone marrow cells by oligonucleated primed in situ hybridization (PRINS). J Pathol. 181:1997;368-373.